BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Diagnosis
512 results:

  • 1. Genetic Signature of Human pancreatic cancer and Personalized Targeting.
    Reshkin SJ; Cardone RA; Koltai T
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607041
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Twelve-month progression-free survival with sotorasib and panitumumab in kras G12C mutant metastatic colorectal cancer.
    Kavgaci G; Dizdar O; Yalcin S
    Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review.
    Kwan MC; Pitman MB; Fernandez-Del Castillo C; Zhang ML
    Gut; 2024 Mar; 73(4):629-638. PubMed ID: 38195219
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Histopathologic diagnosis of solid and cystic pancreatic lesions with a focus on ductal adenocarcinoma : A vademecum for daily practice].
    Esposito I; Yavas A; Häberle L
    Pathologie (Heidelb); 2024 Feb; 45(1):5-18. PubMed ID: 38191761
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mass spectrometry analysis of intact protein
    Xu M; Liu Z; Hu W; Han Y; Wu Z; Chen S; Xia P; DU J; Zhang X; Hao P; Xia J; Yang S
    J Zhejiang Univ Sci B; 2024 Jan; 25(1):51-64. PubMed ID: 38163666
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma.
    Debernardi S; Liszka L; Ntala C; Steiger K; Esposito I; Carlotti E; Baker AM; McDonald S; Graham T; Dmitrovic B; Feakins RM; Crnogorac-Jurcevic T
    Mol Oncol; 2024 Mar; 18(3):677-690. PubMed ID: 38145461
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Precision medicine for kras wild-type pancreatic adenocarcinomas.
    Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
    Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
    Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
    Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. K-ras gene mutation analysis to diagnosis pancreatic adenocarcinoma from endoscopic ultrasound-guided tissue acquisition; a systematic review and meta-analysis.
    Tamura T; Ashida R; Wan K; Shimokawa T; Kitano M
    Pancreatology; 2024 Feb; 24(1):78-87. PubMed ID: 38042675
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical and genomic characterisation of early-onset pancreatic cancer.
    Castet F; Fabregat-Franco C; Castillo G; Navarro V; Sierra A; Acosta DA; López-Valbuena D; Dienstmann R; Tabernero J; Vivancos A; Tian TV; Macarulla T
    Eur J Cancer; 2023 Nov; 194():113338. PubMed ID: 37793216
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in pancreatic cancer.
    Sellahewa R; Moghaddam SM; Lundy J; Jenkins BJ; Croagh D
    Pancreas; 2023 Mar; 52(3):e188-e195. PubMed ID: 37751379
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mutation Analysis of pancreatic Juice and Plasma for the Detection of pancreatic cancer.
    Levink IJM; Jansen MPHM; Azmani Z; van IJcken W; van Marion R; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685923
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comprehensive characterisation of acinar cystic transformation of the pancreas: a systematic review.
    Mattiolo P; Wang H; Basturk O; Brosens LAA; Hong SM; Adsay V; Scarpa A; Luchini C
    J Clin Pathol; 2023 Nov; 76(11):740-746. PubMed ID: 37643836
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. RBPJ Deficiency Sensitizes pancreatic Acinar Cells to kras-Mediated pancreatic Intraepithelial Neoplasia Initiation.
    Pan L; Mulaw MA; Gout J; Guo M; Zarrin H; Schwarz P; Baumann B; Seufferlein T; Wagner M; Oswald F
    Cell Mol Gastroenterol Hepatol; 2023; 16(5):783-807. PubMed ID: 37543088
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Current status of molecular diagnostic approaches using liquid biopsy.
    Takahashi K; Takeda Y; Ono Y; Isomoto H; Mizukami Y
    J Gastroenterol; 2023 Sep; 58(9):834-847. PubMed ID: 37470859
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Single-Molecule Bioelectronic Portable Array for Early diagnosis of pancreatic cancer Precursors.
    Genco E; Modena F; Sarcina L; Björkström K; Brunetti C; Caironi M; Caputo M; Demartis VM; Di Franco C; Frusconi G; Haeberle L; Larizza P; Mancini MT; Österbacka R; Reeves W; Scamarcio G; Scandurra C; Wheeler M; Cantatore E; Esposito I; Macchia E; Torricelli F; Viola FA; Torsi L
    Adv Mater; 2023 Oct; 35(42):e2304102. PubMed ID: 37452695
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients.
    Wang Y; Ge W; Xue S; Cui J; Zhang X; Mao T; Xu H; Li S; Ma J; Yue M; Shentu D; Wang L
    IET Syst Biol; 2023 Aug; 17(4):174-186. PubMed ID: 37341253
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study.
    Hanna L; Sellahewa R; Huggins CE; Lundy J; Croagh D
    Sci Rep; 2023 Jun; 13(1):9663. PubMed ID: 37316578
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The krasCIPANC prospective study.
    Evrard C; Ingrand P; Rochelle T; Martel M; Tachon G; Flores N; Randrian V; Ferru A; Haineaux PA; Goujon JM; Karayan-Tapon L; Tougeron D
    Dig Liver Dis; 2023 Nov; 55(11):1562-1572. PubMed ID: 37308396
    [TBL] [Abstract] [Full Text] [Related]  

  • 20.
    Takase Y; Naito Y; Kawahara A; Okabe Y; Sadashima E; Abe H; Akiba J
    Anticancer Res; 2023 Jun; 43(6):2683-2690. PubMed ID: 37247923
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 26.